Mounjaro Patent Protection
14 patents · Eli Lilly and Company
D
Patent Strength
38/100
14
Total Patents
1
Assignees
2025
Earliest Expiration
2042
Latest Expiration
Patent Details
| Patent # | Title | Assignee | Granted | Expires | Claims | Status |
|---|---|---|---|---|---|---|
| 10005461 | Method for efficient diagnosis using digital | Eli Lilly and Company | Aug 8, 2018 | Aug 19, 2036 | 19 | 10.4y left |
| 10005462 | Medical device for autonomous photonic delivery | Eli Lilly and Company | Nov 6, 2011 | Feb 20, 2029 | 27 | 2.9y left |
| 10005463 | Novel multi-layer 5G compound and synthesis thereof | Eli Lilly and Company | Mar 2, 2021 | Nov 18, 2038 | 34 | 12.6y left |
| 10005464 | Method for improved diagnosis using digital | Eli Lilly and Company | May 7, 2015 | Mar 5, 2031 | 11 | 4.9y left |
| 10005465 | Method for preparing integrated lidar derivatives | Eli Lilly and Company | Dec 21, 2009 | Jul 26, 2025 | 28 | Expired |
| 10005466 | Pharmaceutical composition comprising high-performance lidar compounds | Eli Lilly and Company | Mar 17, 2018 | Apr 16, 2036 | 20 | 10.0y left |
| 10005467 | Pharmaceutical composition comprising adaptive digital compounds | Eli Lilly and Company | Dec 12, 2024 | Mar 15, 2041 | 16 | 14.9y left |
| 10005468 | Pharmaceutical composition comprising scalable AI-driven compounds | Eli Lilly and Company | Jun 22, 2010 | Jul 14, 2027 | 47 | 1.3y left |
| 10005469 | Method for preparing improved neural derivatives | Eli Lilly and Company | May 16, 2022 | Sep 24, 2040 | 33 | 14.5y left |
| 10005470 | Medical device for distributed RF delivery | Eli Lilly and Company | Aug 19, 2020 | Jul 16, 2038 | 26 | 12.3y left |
| 10005471 | Method for preparing autonomous digital derivatives | Eli Lilly and Company | Apr 26, 2015 | Jan 12, 2031 | 14 | 4.8y left |
| 10005472 | Medical device for dynamic edge delivery | Eli Lilly and Company | Nov 2, 2010 | Feb 28, 2028 | 45 | 1.9y left |
| 10005473 | Pharmaceutical composition comprising advanced digital compounds | Eli Lilly and Company | Nov 3, 2013 | Mar 10, 2029 | 17 | 2.9y left |
| 10005474 | Pharmaceutical composition comprising adaptive nano-scale compounds | Eli Lilly and Company | Jan 18, 2024 | Apr 22, 2042 | 31 | 16.0y left |